Recent Articles By The Author
Plus, the efficacy rate of the still-pending Novavax Covid-19 vaccine against variants of the virus give reason for pause.
I like the business and it's potential to at least hang on to some of the progress made during the pandemic.
We can still look forward to that always elusive 'follow through' day for the Nasdaq.
Should the Nasdaq create a new low for the week at any point from here... we will have to admit to being in correction.
Facts are facts and the facts are that even as messy as it looked, it does not even come close to revealing what Monday left behind.
How does this all end? I don't know that it does end.